Houston Chronicle by Todd Ackerman July 27, 2020
Texas A&M University has been selected to mass produce one of the coronavirus vaccine candidates selected as part of the Trump administration’s effort to make such a shot available to Americans in record time.
A university center opened three years ago to develop and manufacture drugs to fight bioterrorist threats and future pandemics, will receive roughly $265 million in federal money to produce tens of millions of doses of the vaccine under a plan announced Monday by President Donald Trump.
“We’ve been preparing for this since we got federal authority to build the center,†said John Sharp, chancellor of Texas A&M System. “We’re pleased to be part of the effort to save lives and protect the country.â€
Texas A&M’s mass production of the vaccine, made by Novavax Inc., likely would begin in early 2021 if ongoing trials show the company’s candidate is safe and effective. The candidate is one of five selected for Operation Warp Speed, the administration’s mammoth project to develop a vaccine by the end of the year, then get it to large numbers of people early in 2021.
More:
https://www.houstonchronicle.com/news/houston-texas/houston/article/A-M-to-mass-produce-one-of-COVID-19-vaccines-15437550.php